<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. )*
CRYENCO SCIENCES
(Name of Issuer)
--------------------------------------
Common Class A
(Title of Class of Securities)
--------------------------------------
22889K204
(CUSIP Number)
--------------------------------------
Check the following box if a fee is being paid with this statement. (A fee
is not required only if the filing person: (1) has a previous statement on
file reporting beneficial ownership of more than five percent of the class
of securities described in Item 1; and (2) has filed no amendment
subsequent thereto reporting beneficial ownership of five percent or less
of such class.) (See Rule 13d-7).
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be
deemed to be ""filed'' for the purpose of Section 18 of the Securities
Exchange Act of 1934 (""Act'') or otherwise subject to the liabilities of
that section of the Act but shall be subject to all other provisions of the
Act (however, see the Notes).
<PAGE>
CUSIP No. 22889K204 13G
---------
- --------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
WELLS FARGO BANK, N.A.
- --------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) / /
(b) / /
- --------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
U.S.A.
- --------------------------------------------------------------------------
NUMBER OF
5 SOLE VOTING POWER
SHARES 321,060
-----------------------------------------------------
BENEFICIALLY 6 SHARED VOTING POWER
9,000
OWNED BY EACH -----------------------------------------------------
7 SOLE DISPOSITIVE POWER
REPORTING 311,940
------------------------------------------------------
PERSON WITH 8 SHARED DISPOSITIVE POWER
11,000
- ---------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
330,060
- ---------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
- ---------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
6.4%
- ---------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
Bank
- ---------------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Schedule 13G
Under the Securities Exchange Act of 1934
- -----------------------------------------------------------------------------
Item 1(a). Name of Issuer:
--------------
Cryenco Sciences, Inc.
Item 1(b). Address of Issuer's Principal Executive Offices:
------------------------------------------------
3811 Joliet Street
Denver, CO 80239
Item 2(c). Name of Person Filing:
---------------------
Wells Fargo Bank
National Association
Item 2(b). Address or Principal Business Office or, if None, Residence:
-----------------------------------------------------------
464 California Street
San Francisco, California 94163
Item 2(c). Citizenship:
-----------
U.S.A.
Item 2(d). Title of Class of Securities:
----------------------------
Common Stock
Item 2(e). CUSIP Number:
------------
22889K204
Item 3. The Persons Filing This Schedule, Pursuant to Paragraph
-------------------------------------------------------
240.13d-1(b) are a:
-------------------
(b) (X) Bank as defined in Section 3(a)(6) of the Act.
Item 4. Ownership:
----------
See items 5-11 of cover page.
Item 5. Ownership of Five Percent or Less of a Class:
---------------------------------------------
Not applicable.
Item 6. Ownership of More Than Five Percent on Behalf of Another Person:
----------------------------------------------------------------
The shares reported are held by the Bank in trust
accounts for the economic benefit of the beneficiaries
of those accounts.
<PAGE>
Item 7. Identification and Classification of the Subsidiary Which
---------------------------------------------------------
Acquired the Security Being Reported on by the Parent Holding
-------------------------------------------------------------
Company:
--------
Not applicable.
Item 8. Identification and Classification of Members of the Group:
---------------------------------------------------------
Not applicable.
Item 9. Notice of Dissolution of Group:
------------------------------
Not applicable.
Item 10. Certification:
-------------
By signing below I certify that, to the best of
my knowledge and belief, the securities referred
to above were acquired in the ordinary course of
business and were not acquired for the purpose of and
do not have the effect of changing or influencing the
control of the issuer of such securities and were not
acquired in connection with or as a participant in
any transaction having such purposes or effect.
Signature:
----------
After reasonable inquiry and to the best of my knowledge
and belief, I certify that the information set forth in
this statement is true, complete and correct.
By:
- ------------ -------------------------
Date GUY ROUNSAVILLE, JR.
Executive Vice President,
Chief Counsel and Secretary
WELLS FARGO BANK, N.A.
By:
- ------------ --------------------------
Date GUY ROUNSAVILLE, JR.
Executive Vice President,
Chief Counsel and Secretary
WELLS FARGO AND COMPANY
